HMVSX
Price
$17.73
Change
-$0.01 (-0.06%)
Updated
Jul 18 closing price
Net Assets
1.15B
VMVIX
Price
$65.84
Change
+$0.17 (+0.26%)
Updated
Jul 18 closing price
Net Assets
30.57B
Interact to see
Advertisement

HMVSX vs VMVIX

Header iconHMVSX vs VMVIX Comparison
Open Charts HMVSX vs VMVIXBanner chart's image
Hartford MidCap Value R4
Price$17.73
Change-$0.01 (-0.06%)
VolumeN/A
Net Assets1.15B
Vanguard Mid-Cap Value Index Investor
Price$65.84
Change+$0.17 (+0.26%)
VolumeN/A
Net Assets30.57B
HMVSX vs VMVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HMVSX vs. VMVIX commentary
Jul 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HMVSX is a Buy and VMVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 30.6B vs. HMVSX (1.15B). VMVIX pays higher dividends than HMVSX: VMVIX (2.14) vs HMVSX (0.50). HMVSX was incepted earlier than VMVIX: HMVSX (15 years) vs VMVIX (19 years). HMVSX (1.18) is less costly to investors than VMVIX (0.19). HMVSX is a more actively managed with annual turnover of: 132.00 vs. VMVIX (19.00). HMVSX has a lower initial minimum investment than VMVIX: HMVSX (0) vs VMVIX (3000). VMVIX annual gain was more profitable for investors over the last year : 5.78 vs. HMVSX (-7.10). VMVIX return over 5 years is better than : 68.95 vs. HMVSX (36.07).
HMVSXVMVIXHMVSX / VMVIX
Total Expense Ratio1.180.19621%
Annual Report Gross Expense Ratio1.180.19621%
Fund Existence15 years19 years-
Gain YTD1.5463.18149%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.15B30.6B4%
Annual Yield % from dividends0.502.1423%
Returns for 1 year-7.105.78-123%
Returns for 3 years6.0728.9321%
Returns for 5 years36.0768.9552%
Returns for 10 years9.9987.1711%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DDS461.6720.56
+4.66%
Dillards
JANX27.750.75
+2.78%
Janux Therapeutics
SKYH10.360.23
+2.27%
Sky Harbour Group Corporation
CLST12.280.01
+0.08%
Catalyst Bancorp
TDACU10.43N/A
N/A
Translational Development Acquisition Corp